No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
WGS240816C35000
- 3.50
- +0.10+2.94%
15min DelayTrading Jul 22 09:49 ET
3.50High3.35Low
3.35Open3.40Pre Close16 Volume55 Open Interest35.00Strike Price5.38KTurnover133.07%IV21.60%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry3.50Extrinsic Value100Contract SizeAmericanOptions Type0.4892Delta0.0349Gamma9.74Leverage Ratio-0.0917Theta0.0086Rho4.77Eff Leverage0.0343Vega
Intraday
- 5D
- Daily
News
Several Insiders Invested In GeneDx Holdings Flagging Positive News
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in GeneDx Holdings Corp.'s (NASDAQ:WGS) case, it's fantastic news for
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
GeneDx Holdings Corp. (NASDAQ:WGS) has made the biggest gains on the Russell 2000 Index in 2024 as the biotechnology company moves toward more comprehensive genetic testing.The Maryland-based company'
What Makes GeneDx Holdings Corp. (WGS) a Strong Momentum Stock: Buy Now?
GeneDx Holdings Price Target Raised to $28.00/Share From $12.50 by Goldman Sachs
GeneDx Holdings Price Target Raised to $28.00/Share From $12.50 by Goldman
Express News | Goldman Sachs Maintains Neutral on GeneDx Hldgs, Raises Price Target to $28
Express News | GeneDx Holdings Corp : TD Cowen Raises Target Price to $46 From $24
Comments
Hello Mooers! ![]()
A quick recap for the month ending April 30, 2024.
![]()
Ten stocks with >300% YTD
![]()
$Swvl Holdings(SWVL.US$718.40%
![]()
$Root Inc(ROOT.US$564.60%
![]()
$Elevation Oncology(ELEV.US$561.08%
![]()
$JanOne(JAN.US$554.05%
![]()
$GeneDx Holdings(WGS.US$520.71%
![]()
$Corbus Pharmaceuticals(CRBP.US$513.25%
![]()
$AGBA Group(AGBA.US$482.90%
![]()
$Janux Therapeutics(JANX.US$431.22%
![]()
$Dave Inc(DAVE.US$4...
A quick recap for the month ending April 30, 2024.
4
1
$GeneDx Holdings(WGS.US$
NEWS
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
NEWS
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
1
The low P/S of GeneDx Holdings indicates investors expect limited future growth. A recent share price boost hasn't shifted investor perceptions. The low P/S is largely because shareholders are pessimistic about revenue prospects.
Read more
Mars MoooOP :